Comparison
Framework vs Hims
Independent, side-by-side. Same methodology, same sourcing standard, no payment accepted from either. Prices are observed market pricing (snapshot 2026-07-20); receipts are computed from sourced records.
| Framework | Hims | |
|---|---|---|
| Verdict | Profile in progress | Profile in progress |
| Tirzepatide price | from $158/mo (6-mo titration pack) | Not tracked |
| Semaglutide price | from $88/mo (6-mo titration pack) | from $199/mo (12-mo prepay) |
| Pharmacy receipt | Fills through Absolute Pharmacy, Nova per market data (not the clinic's own disclosure). Pick your state to check licenses. | Names its pharmacy (Strive Pharmacy, Curexa +1) — Strive Pharmacy, RedRock Pharmacy state-verified by us in up to 17 states. Pick your state to check yours. |
| Care receipt | Care is outsourced to Beluga Health — a contract medical group named on the clinic's own site. The brand doesn't employ your clinician. | Care is outsourced to You Health — a contract medical group named on the clinic's own site. The brand doesn't employ your clinician. |
| Review integrity | Review-integrity flag — 100% of its Trustpilot reviews are unprompted "organic" posts, past our 40% gaming threshold. | Review-integrity flag — 72% of its Trustpilot reviews are unprompted "organic" posts, past our 40% gaming threshold. |
| Company address | Its listed address is a registered-agent or mailbox service — no operating location stands behind the brand's listed address. | Its listed address is a registered-agent or mailbox service — no operating location stands behind the brand's listed address. |
| Pharmacy | In review | In review |
| Clinical support | In review | In review |
| Patient support | In review | In review |
| Value | In review | In review |
| Ships to | In review | In review |
| Pharmacy model | Compounded semaglutide and tirzepatide described as 'compounded medications prepared by licensed compounding pharmacies' that are not FDA-approved. Framework states it 'acts as a technology platform connecting users with Physicians and pharmacies' and 'is not a health care provider or pharmacy.' No specific compounding pharmacy partner is named on public pages reviewed. | Hims is unusually vertically integrated for a GLP-1 telehealth brand: Hims & Hers Health, Inc. owns and operates its own pharmacy and manufacturing chain rather than only contracting out. Per its FY2025 Form 10-K, the company operates two licensed 503A mail-order pharmacies that fill solely for its own customers - Apostrophe Pharmacy LLC and XeCare, LLC, both now wholly-owned subsidiaries - plus a licensed 503B outsourcing facility, MedisourceRx (acquired September 2024 as Seaview Enterprises, LLC, for $31.0 million; Los Alamitos, CA), which compounded its injectable semaglutide, and a peptide manufacturing facility. The consumer Terms also name third-party partner pharmacies (EHT Pharmacy LLC dba Curexa, CD Pharmacy LLC dba Red Rock Pharmacy, AnazaoHealth Corporation, and Strive Specialties, Inc.). During the April-June 2025 Novo Nordisk bundle, brand-name Wegovy was dispensed through Novo's own NovoCare Pharmacy accessed via the Hims platform. Prescriptions are written by providers in affiliated 'You Health' professional medical groups; Hims & Hers states in its Terms that it is not itself a healthcare provider. |
| Red flags on file | 4 | 5 |
Visit yourframework.com
Plain link, not sponsored — we take no payment for this.
Visit hims.com
Plain link, not sponsored — we take no payment for this.
Full profiles: Framework → · Hims →
State-aware license reads: the tirzepatide price board →